121 related articles for article (PubMed ID: 38268430)
1. Birth characteristics as predictors of respiratory syncytial virus hospitalisation in newborns to optimise immunisation schedule.
Amodio E; Pisciotta V; Genovese D; Vella G; Verso MG; Giuffrè M; Vitale F
Acta Paediatr; 2024 May; 113(5):1087-1094. PubMed ID: 38268430
[TBL] [Abstract][Full Text] [Related]
2. The role of birth month in the burden of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in Croatia.
Li Y; Batinović E; Milić P; Markić J
PLoS One; 2022; 17(9):e0273962. PubMed ID: 36054117
[TBL] [Abstract][Full Text] [Related]
3. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
Na'amnih W; Kassem E; Tannous S; Kagan V; Jbali A; Hanukayev E; Freimann S; Obolski U; Muhsen K
Epidemiol Infect; 2022 Feb; 150():e45. PubMed ID: 35105415
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.
Chida-Nagai A; Sato H; Sato I; Shiraishi M; Sasaki D; Izumi G; Yamazawa H; Cho K; Manabe A; Takeda A
Eur J Pediatr; 2022 Feb; 181(2):539-547. PubMed ID: 34417646
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus hospitalisations among young children: a data linkage study.
Prasad N; Newbern EC; Trenholme AA; Wood T; Thompson MG; Aminisani N; Huang QS; Grant CC
Epidemiol Infect; 2019 Jan; 147():e246. PubMed ID: 31364578
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
8. Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants.
Giannini F; Hogan AB; Sarna M; Glass K; Moore HC
BMC Infect Dis; 2024 May; 24(1):510. PubMed ID: 38773455
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.
Fortunato F; Campanozzi A; Maffei G; Arena F; Carri VD; Rollo T; Lopalco PL; Martinelli D
Ital J Pediatr; 2024 Mar; 50(1):45. PubMed ID: 38454523
[TBL] [Abstract][Full Text] [Related]
10. Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015.
Jepsen MT; Trebbien R; Emborg HD; Krause TG; Schønning K; Voldstedlund M; Nielsen J; Fischer TK
Euro Surveill; 2018 Jan; 23(3):. PubMed ID: 29386093
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus testing during bronchiolitis episodes of care in an integrated health care delivery system: a retrospective cohort study.
Flaherman V; Li S; Ragins A; Masaquel A; Kipnis P; Escobar GJ
Clin Ther; 2010 Dec; 32(13):2220-9. PubMed ID: 21316538
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
Dovizio M; Veronesi C; Bartolini F; Cavaliere A; Grego S; Pagliaro R; Procacci C; Ubertazzo L; Bertizzolo L; Muzii B; Parisi S; Perrone V; Baraldi E; Bozzola E; Mosca F; Esposti LD
Ital J Pediatr; 2024 Mar; 50(1):57. PubMed ID: 38528616
[TBL] [Abstract][Full Text] [Related]
13. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.
Hardelid P; Verfuerden M; McMenamin J; Smyth RL; Gilbert R
Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621817
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and associated factors for hospitalization related respiratory syncytial virus infection among children less than 5 years of age in Northern Thailand.
Chaiut W; Sapbamrer R; Dacha S; Sudjaritruk T; Malasao R
J Infect Public Health; 2023 Oct; 16(10):1659-1665. PubMed ID: 37633227
[TBL] [Abstract][Full Text] [Related]
15. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Garegnani L; Styrmisdóttir L; Roson Rodriguez P; Escobar Liquitay CM; Esteban I; Franco JV
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013757. PubMed ID: 34783356
[TBL] [Abstract][Full Text] [Related]
16. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan.
Khuri-Bulos N; Lawrence L; Piya B; Wang L; Fonnesbeck C; Faouri S; Shehabi A; Vermund SH; Williams JV; Halasa NB
BMJ Open; 2018 May; 8(5):e021898. PubMed ID: 29780032
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus-associated hospitalisations in Australia, 2006-2015.
Saravanos GL; Sheel M; Homaira N; Dey A; Brown E; Wang H; Macartney K; Wood NJ
Med J Aust; 2019 Jun; 210(10):447-453. PubMed ID: 31066061
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries.
Biggs HM; Simões EAF; Abu Khader I; Thompson MG; Gordon A; Hunt DR; DeGroote NP; Porter RM; Bino S; Marar BI; Gresh L; de Jesus-Cornejo J; Langley G; Thornburg NJ; Peret TCT; Whitaker B; Zhang Y; Wang L; Patel MC; McMorrow M; Campbell W; Hasibra I; Duka E; Al-Gazo M; Kubale J; Sanchez F; Lucero MG; Tallo VL; Azziz-Baumgartner E; Simaku A; Gerber SI;
J Pediatric Infect Dis Soc; 2023 Jul; 12(7):394-405. PubMed ID: 37313727
[TBL] [Abstract][Full Text] [Related]
19. Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis.
Cong B; Dighero I; Zhang T; Chung A; Nair H; Li Y
BMC Med; 2023 Jun; 21(1):224. PubMed ID: 37365569
[TBL] [Abstract][Full Text] [Related]
20. The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs.
Roy Á; Polazzi S; Ploin D; Gillet Y; Javouhey E; Lina B; ; Myard-Dury AF; Couray-Targe S; Duclos A; Casalegno JS
Vaccine; 2023 Jun; 41(25):3796-3800. PubMed ID: 37198017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
